Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Capital Expenditures (2016 - 2026)

Apyx Medical filings provide 15 years of Capital Expenditures readings, the most recent being $275000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 12.24% to $275000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 54.29% increase, with the full-year FY2025 number at $1.1 million, up 54.29% from a year prior.
  • Capital Expenditures hit $275000.0 in Q4 2025 for Apyx Medical, down from $519000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $519000.0 in Q3 2025 to a low of $29000.0 in Q2 2021.
  • Median Capital Expenditures over the past 5 years was $181000.0 (2022), compared with a mean of $205100.0.
  • The widest YoY moves for Capital Expenditures: up 1788.89% in 2021, down 69.15% in 2021.
  • Apyx Medical's Capital Expenditures stood at $332000.0 in 2021, then tumbled by 57.23% to $142000.0 in 2022, then plummeted by 34.51% to $93000.0 in 2023, then soared by 163.44% to $245000.0 in 2024, then rose by 12.24% to $275000.0 in 2025.
  • The last three reported values for Capital Expenditures were $275000.0 (Q4 2025), $519000.0 (Q3 2025), and $265000.0 (Q2 2025) per Business Quant data.